DK2307441T3 - Fremgangsmåde til fremstilling af insulinforbindelser - Google Patents

Fremgangsmåde til fremstilling af insulinforbindelser Download PDF

Info

Publication number
DK2307441T3
DK2307441T3 DK08876705.8T DK08876705T DK2307441T3 DK 2307441 T3 DK2307441 T3 DK 2307441T3 DK 08876705 T DK08876705 T DK 08876705T DK 2307441 T3 DK2307441 T3 DK 2307441T3
Authority
DK
Denmark
Prior art keywords
procedure
insulin compounds
manufacturing
manufacturing insulin
compounds
Prior art date
Application number
DK08876705.8T
Other languages
English (en)
Inventor
Partha Hazra
Srikanth Gollarahosahalli Sathyanarayana
Suma Sreenivas
Manjunath Hadavanahalli Shivarudraiah
Kedarnath Nanjund Sastry
Harish Iyer
Original Assignee
Biocon Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocon Ltd filed Critical Biocon Ltd
Application granted granted Critical
Publication of DK2307441T3 publication Critical patent/DK2307441T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/06Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK08876705.8T 2008-08-07 2008-09-19 Fremgangsmåde til fremstilling af insulinforbindelser DK2307441T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1904CH2008 2008-08-07
PCT/IN2008/000598 WO2010016069A1 (en) 2008-08-07 2008-09-19 A process for preparation of insulin compounds

Publications (1)

Publication Number Publication Date
DK2307441T3 true DK2307441T3 (da) 2016-05-23

Family

ID=41663319

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08876705.8T DK2307441T3 (da) 2008-08-07 2008-09-19 Fremgangsmåde til fremstilling af insulinforbindelser

Country Status (15)

Country Link
US (1) US9090705B2 (da)
EP (1) EP2307441B1 (da)
JP (2) JP5903269B2 (da)
KR (1) KR20110059602A (da)
CN (1) CN102159588B (da)
BR (1) BRPI0823004B8 (da)
DK (1) DK2307441T3 (da)
ES (1) ES2570937T3 (da)
HK (1) HK1156046A1 (da)
IL (1) IL211053A (da)
MX (1) MX2011001408A (da)
MY (1) MY188456A (da)
PL (1) PL2307441T3 (da)
RU (1) RU2458989C1 (da)
WO (1) WO2010016069A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2515061C1 (ru) * 2013-04-29 2014-05-10 Общество с ограниченной ответственностью "БиоКлонТек" РЕКОМБИНАТНАЯ ПЛАЗМИДНАЯ ДНК рНI03 КОДИРУЮЩАЯ, ГИБРИДНЫЙ БЕЛОК С ПРОИНСУЛИНОМ ЧЕЛОВЕКА, КЛЕТКА Escherichia coli, ТРАНСФОРМИРОВАННАЯ РЕКОМБИНАНТНОЙ ПЛАЗМИДНОЙ ДНК рНI03, И ШТАММ БАКТЕРИЙ Escherichia coli JM109/pHI03-ПРОДУЦЕНТ ГИБРИДНОГО БЕЛКА-ПРЕДШЕСТВЕННИКА ИНСУЛИНА ЧЕЛОВЕКА
RU2514480C1 (ru) * 2013-04-29 2014-04-27 Общество с ограниченной ответственностью "БиоКлонТек" РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pHILP07, КОДИРУЮЩАЯ ГИБРИДНЫЙ БЕЛОК С ПРОИНСУЛИНОМ Lispro ЧЕЛОВЕКА, КЛЕТКА Escherichia coli, ТРАНСФОРМИРОВАННАЯ РЕКОМБИНАНТНОЙ ПЛАЗМИДНОЙ ДНК pHILP07, И ШТАММ БАКТЕРИЙ Escherichia coli JM109/pHILP07-ПРОДУЦЕНТ ГИБРИДНОГО БЕЛКА С ПРОИНСУЛИНОМ Lispro ЧЕЛОВЕКА
RU2514578C1 (ru) * 2013-04-29 2014-04-27 Общество с ограниченной ответственностью "БиоКлонТек" РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pHIASP03, КОДИРУЮЩАЯ ГИБРИДНЫЙ БЕЛОК С ПРОИНСУЛИНОМ Aspart ЧЕЛОВЕКА, КЛЕТКА Escherichia coli, ТРАНСФОРМИРОВАННАЯ РЕКОМБИНАНТНОЙ ПЛАЗМИДНОЙ ДНК pHIAsp03, И ШТАММ БАКТЕРИЙ Escherichia coli JM109/pHIAsp03-ПРОДУЦЕНТ ГИБРИДНОГО БЕЛКА С ПРОИНСУЛИНОМ Aspart ЧЕЛОВЕКА
JP2018531007A (ja) * 2015-09-24 2018-10-25 ハンミ ファーマシューティカル カンパニー リミテッド インスリンの製造方法
EP3500586B1 (en) * 2016-10-17 2021-02-24 Enzene Biosciences Ltd. Continuous process for reducing heterogeneity of therapeutic protein
CN108164594B (zh) * 2017-12-08 2020-03-31 珠海冀百康生物科技有限公司 一种去b链30位氨基酸残基的胰岛素前体沉淀的回收方法
US20210230659A1 (en) * 2018-06-18 2021-07-29 Unichem Laboratories Ltd Leader Sequence for Higher Expression of Recombinant Proteins
KR20200080747A (ko) * 2018-12-27 2020-07-07 주식회사 폴루스 인슐린 전구체의 인슐린 효소 전환용 조성물 및 이를 이용하여 인슐린 전구체를 인슐린으로 전환하는 방법
RU2729737C1 (ru) * 2019-05-24 2020-08-11 Закрытое акционерное общество "ФАРМ-ХОЛДИНГ" РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pF882, КОДИРУЮЩАЯ ГИБРИДНЫЙ ПОЛИПЕПТИД, СОДЕРЖАЩИЙ В30-ДЕЗТРЕОНИН-ИНСУЛИН, И ШТАММ БАКТЕРИЙ Escherichia coli - ПРОДУЦЕНТ ГИБРИДНОГО ПОЛИПЕПТИДА, СОДЕРЖАЩЕГО В30-ДЕЗТРЕОНИН-ИНСУЛИН
CN114805544B (zh) * 2022-06-23 2022-09-09 北京惠之衡生物科技有限公司 一种赖脯胰岛素前体、其重组基因工程菌及其构建方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2819999A (en) * 1953-11-13 1958-01-14 Novo Terapeutisk Labor As Process for crystallization of insulin using freeze dried insulin as seeding material
US3069323A (en) * 1959-09-14 1962-12-18 Armour Pharma Insulin recovery process
DE3209184A1 (de) 1982-03-13 1983-09-15 Hoechst Ag, 6230 Frankfurt Verfahren zur umwandlung von praeproinsulinanaloga zu insulinen
DE3440988A1 (de) 1984-11-09 1986-07-10 Hoechst Ag, 6230 Frankfurt Verfahren zur spaltung von peptiden und proteinen an der methionyl-bindung
DK347086D0 (da) 1986-07-21 1986-07-21 Novo Industri As Novel peptides
DK129385A (da) 1985-03-22 1986-09-23 Novo Industri As Peptider og fremstilling deraf
PH25772A (en) 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
CA1339955C (en) 1986-10-14 1998-07-14 Richard Eugene Heiney Process for transforming a human insulin precursor to human insulin
CA1339416C (en) 1987-02-25 1997-09-02 Liselotte Langkjaer Insulin derivatives
DE58906966D1 (de) 1988-06-23 1994-03-24 Hoechst Ag Mini-Proinsulin, seine Herstellung und Verwendung.
ES2081826T3 (es) 1988-11-03 1996-03-16 Hoechst Ag Procedimiento para la preparacion de un producto previo de insulina en estreptomicetos.
US6011007A (en) 1993-09-17 2000-01-04 Novo Nordisk A/S Acylated insulin
JP3014764B2 (ja) 1993-09-17 2000-02-28 ノボ ノルディスク アクティーゼルスカブ アシル化インスリン
US6001604A (en) * 1993-12-29 1999-12-14 Bio-Technology General Corp. Refolding of proinsulins without addition of reducing agents
DE60335797D1 (de) * 2002-05-07 2011-03-03 Novo Nordisk As Lösliche formulierungen, die monomeres insulin und acyliertes insulin enthalten
EP1563075A4 (en) 2002-11-12 2006-09-06 Ckd Bio Corp HUMANINSULIN EXPRESSIVE PLASMIDE AND METHOD FOR THE PRODUCTION OF HUMANINSULIN THEREWITH
ES2546016T3 (es) 2005-10-13 2015-09-17 Biocon Limited Procedimiento para la preparación de conjugados de insulina
AR072563A1 (es) * 2009-07-15 2010-09-08 Beta Lab Sa Un procedimiento para obtener insulina aspartica que utiliza una cepa de levaduras de pichia pastoris

Also Published As

Publication number Publication date
EP2307441A1 (en) 2011-04-13
MY188456A (en) 2021-12-10
CN102159588A (zh) 2011-08-17
CN102159588B (zh) 2015-09-02
JP2014050402A (ja) 2014-03-20
US9090705B2 (en) 2015-07-28
KR20110059602A (ko) 2011-06-02
RU2458989C1 (ru) 2012-08-20
JP5903269B2 (ja) 2016-04-13
EP2307441A4 (en) 2012-08-22
IL211053A (en) 2016-08-31
JP5909478B2 (ja) 2016-04-26
WO2010016069A9 (en) 2011-08-11
ES2570937T3 (es) 2016-05-23
BRPI0823004A2 (pt) 2012-05-29
BRPI0823004B8 (pt) 2021-05-25
IL211053A0 (en) 2011-04-28
PL2307441T3 (pl) 2016-09-30
MX2011001408A (es) 2011-05-02
JP2011530501A (ja) 2011-12-22
US20110159538A1 (en) 2011-06-30
BRPI0823004B1 (pt) 2021-03-30
EP2307441B1 (en) 2016-03-23
HK1156046A1 (zh) 2012-06-01
WO2010016069A1 (en) 2010-02-11

Similar Documents

Publication Publication Date Title
DK2167613T3 (da) Fremgangsmåde til fremstilling af biobrændsler
DK2662352T3 (da) Fremgangsmåde til fremstilling af phenylacetamidforbindelse
DK2149545T3 (da) Fremgangsmåde til fremstilling af en benzaldehydforbindelse
DK2288375T3 (da) Pegylerede insulin-lispro-forbindelser
BRPI0920707A2 (pt) compostos
DK2242759T3 (da) Forbindelser
DK2035166T3 (da) Fremgangsmåde til fremstilling af beholdere
DK2307441T3 (da) Fremgangsmåde til fremstilling af insulinforbindelser
SMT201600045B (it) Composti tetraciclinici c7-fluoro sostituiti
DK2467204T3 (da) Fremgangsmåde til fremstilling af en sorbent
DK2334639T3 (da) Fremgangsmåder til fremstilling af aminosulfonforbindelser
DK2496562T3 (da) Fremgangsmåde til fremstilling af calcobutrol
BRPI0914254A2 (pt) compostos anti-infectivos
DK2366113T3 (da) Dgnss-korrektion til positionering
DK2595948T3 (da) Fremgangsmåde til fremstilling af ingenol-3-angelat
BRPI0918602A2 (pt) composto (i)
DK2358661T3 (da) Fremgangsmåde til fremstilling af trans-4-amino-cyclohexyl-eddikesyreethylester-hcl
DK2297162T3 (da) Forbindelser
DK2310613T3 (da) Forbedret brudled til stigrør
DK3214083T3 (da) Fremgangsmåde til fremstilling af quinolonforbindelser
DK2421819T3 (da) Fremgangsmåde til iodering af aromatiske forbindelser
DK2342346T3 (da) Thermotoga til behandling af biomasse
BRPI0916432A2 (pt) compostos
DK2241546T3 (da) Fremgangsmåde til fremstilling af en benzaldehydforbindelse
BRPI0923592A2 (pt) composto